BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, Lin HC. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis. 2004;63:450-452. [PMID: 15020342 DOI: 10.1136/ard.2003.011502] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Tomasello G, Mazzola M, Bosco V, Tomasello G, Damiani P, Sinagra E, Carini F. Intestinal dysbiosis and hormonal neuroendocrine secretion in the fibromyalgic patient: Relationship and correlations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018. [PMID: 30209437 DOI: 10.5507/bp.2018.051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Frissora CL, Koch KL. Symptom overlap and comorbidity of irritable bowel syndrome with other conditions. Curr Gastroenterol Rep. 2005;7:264-271. [PMID: 16042909 DOI: 10.1007/s11894-005-0018-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis]
3 Grant MC, Baker JS. An overview of the effect of probiotics and exercise on mood and associated health conditions. Critical Reviews in Food Science and Nutrition 2016;57:3887-93. [DOI: 10.1080/10408398.2016.1189872] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
4 Calandre EP, Hidalgo-Tallon J, Molina-Barea R, Rico-Villademoros F, Molina-Hidalgo C, Garcia-Leiva JM, Carrillo-Izquierdo MD, Slim M. The Probiotic VSL#3® Does Not Seem to Be Efficacious for the Treatment of Gastrointestinal Symptomatology of Patients with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Pharmaceuticals (Basel) 2021;14:1063. [PMID: 34681287 DOI: 10.3390/ph14101063] [Reference Citation Analysis]
5 Ghoshal UC, Nehra A, Mathur A, Rai S. A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome. J Gastroenterol Hepatol 2020;35:922-31. [PMID: 31750966 DOI: 10.1111/jgh.14938] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
6 Odenwald MA, Turner JR. Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol 2013;11:1075-83. [PMID: 23851019 DOI: 10.1016/j.cgh.2013.07.001] [Cited by in Crossref: 170] [Cited by in F6Publishing: 165] [Article Influence: 18.9] [Reference Citation Analysis]
7 Duque L, Fricchione G. Fibromyalgia and its New Lessons for Neuropsychiatry. Med Sci Monit Basic Res 2019;25:169-78. [PMID: 31273184 DOI: 10.12659/MSMBR.915962] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
8 Slim M, Calandre EP, Rico-Villademoros F. An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms. Rheumatol Int 2015;35:433-44. [PMID: 25119830 DOI: 10.1007/s00296-014-3109-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
9 Rana SV, Malik A. Breath tests and irritable bowel syndrome. World J Gastroenterol. 2014;20:7587-7601. [PMID: 24976698 DOI: 10.3748/wjg.v20.i24] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Shah ED, Basseri RJ, Chong K, Pimentel M. Abnormal Breath Testing in IBS: A Meta-Analysis. Dig Dis Sci 2010;55:2441-9. [DOI: 10.1007/s10620-010-1276-4] [Cited by in Crossref: 104] [Cited by in F6Publishing: 87] [Article Influence: 8.7] [Reference Citation Analysis]
11 Weinstock LB, Zeiss S. Rifaximin antibiotic treatment for restless legs syndrome: a double-blind, placebo-controlled study: Antibiotic therapy for RLS. Sleep and Biological Rhythms 2012;10:145-53. [DOI: 10.1111/j.1479-8425.2012.00537.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Erdrich S, Hawrelak JA, Myers SP, Harnett JE. A systematic review of the association between fibromyalgia and functional gastrointestinal disorders. Therap Adv Gastroenterol 2020;13:1756284820977402. [PMID: 33343707 DOI: 10.1177/1756284820977402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Quigley EM. The efficacy of probiotics in IBS. J Clin Gastroenterol 2008;42 Suppl 2:S85-90. [PMID: 18542036 DOI: 10.1097/MCG.0b013e31816244ca] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
14 Simrén M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut 2006;55:297-303. [PMID: 16474100 DOI: 10.1136/gut.2005.075127] [Cited by in Crossref: 277] [Cited by in F6Publishing: 234] [Article Influence: 17.3] [Reference Citation Analysis]
15 Grover M, Drossman DA. Psychopharmacologic and behavioral treatments for functional gastrointestinal disorders. Gastrointest Endosc Clin N Am. 2009;19:151-170, vii-viii. [PMID: 19232286 DOI: 10.1016/j.giec.2008.12.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
16 Coelho LK, Carvalho NS, Navarro-Rodriguez T, Marson FAL, Carvalho PJPC. Lactulose Breath Testing Can Be a Positive Predictor Before Weight Gain in Participants with Obesity Submitted to Roux-en-Y Gastric Bypass. Obes Surg 2019;29:3457-64. [PMID: 31187458 DOI: 10.1007/s11695-019-04006-z] [Reference Citation Analysis]
17 Weinstock LB, Fern SE, Duntley SP. Restless legs syndrome in patients with irritable bowel syndrome: response to small intestinal bacterial overgrowth therapy. Dig Dis Sci. 2008;53:1252-1256. [PMID: 17934858 DOI: 10.1007/s10620-007-0021-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
18 Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, Vorisek V, Kopacova M. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16(24): 2978-2990 [PMID: 20572300 DOI: 10.3748/wjg.v16.i24.2978] [Cited by in CrossRef: 327] [Cited by in F6Publishing: 242] [Article Influence: 27.3] [Reference Citation Analysis]
19 Rana SV, Malik A. Breath tests and irritable bowel syndrome. World J Gastroenterol 2014; 20(24): 7587-7601 [PMID: 24976698 DOI: 10.3748/wjg.v20.i24.7587] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
20 Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, Peláez-Luna M, Remes-Troche JM, Tamayo JL, Valdovinos MA. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review. Rev Gastroenterol Mex. 2014;79:96-134. [PMID: 24857420 DOI: 10.1016/j.rgmx.2014.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
21 Weinstock LB, Walters AS, Paueksakon P. Restless legs syndrome--theoretical roles of inflammatory and immune mechanisms. Sleep Med Rev 2012;16:341-54. [PMID: 22258033 DOI: 10.1016/j.smrv.2011.09.003] [Cited by in Crossref: 81] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
22 Rana SV, Sharma S, Kaur J, Prasad KK, Sinha SK, Kochhar R, Malik A, Morya RK. Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients. J Crohns Colitis. 2014;8:859-865. [PMID: 24456736 DOI: 10.1016/j.crohns.2014.01.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
23 Seaman DR. Toxins, Toxicity, and Endotoxemia: A Historical and Clinical Perspective for Chiropractors. J Chiropr Humanit 2016;23:68-76. [PMID: 27920621 DOI: 10.1016/j.echu.2016.07.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Borji R, Fereshtehnejad SM, Taba Taba Vakili S, Daryani NE, Ajdarkosh H. Association between irritable bowel syndrome and restless legs syndrome: a comparative study with control group. J Neurogastroenterol Motil 2012;18:426-33. [PMID: 23106004 DOI: 10.5056/jnm.2012.18.4.426] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
25 Slingerland AE, Schwabkey Z, Wiesnoski DH, Jenq RR. Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol 2017;8:400. [PMID: 28446909 DOI: 10.3389/fimmu.2017.00400] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
26 Haddad HW, Mallepalli NR, Scheinuk JE, Bhargava P, Cornett EM, Urits I, Kaye AD. The Role of Nutrient Supplementation in the Management of Chronic Pain in Fibromyalgia: A Narrative Review. Pain Ther 2021. [PMID: 33909266 DOI: 10.1007/s40122-021-00266-9] [Reference Citation Analysis]
27 Frissora CL, Cash BD. Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome. Aliment Pharmacol Ther. 2007;25:1271-1281. [PMID: 17509095 DOI: 10.1111/j.1365-2036.2007.03313.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
28 Chu H, Fox M, Zheng X, Deng Y, Long Y, Huang Z, Du L, Xu F, Dai N. Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. Gastroenterol Res Pract. 2016;2016:3230859. [PMID: 27379166 DOI: 10.1155/2016/3230859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yamini D, Pimentel M. Irritable bowel syndrome and small intestinal bacterial overgrowth. J Clin Gastroenterol. 2010;44:672-675. [PMID: 20838236 DOI: 10.1097/mcg.0b013e3181ef3476] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
30 Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver. 2017;11:196-208. [PMID: 28274108 DOI: 10.5009/gnl16126] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 14.0] [Reference Citation Analysis]
31 Hsu YC, Yang HY, Huang WT, Chen SC, Lee HS. Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study. PLoS One 2019;14:e0220641. [PMID: 31369638 DOI: 10.1371/journal.pone.0220641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Ohman L, Simrén M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis. 2007;39:201-215. [PMID: 17267314 DOI: 10.1016/j.dld.2006.10.014] [Cited by in Crossref: 96] [Cited by in F6Publishing: 100] [Article Influence: 6.4] [Reference Citation Analysis]
33 Park JS, Yu JH, Lim HC, Kim JH, Yoon YH, Park HJ, Lee SI. [Usefulness of lactulose breath test for the prediction of small intestinal bacterial overgrowth in irritable bowel syndrome]. Korean J Gastroenterol. 2010;56:242-248. [PMID: 20962560 DOI: 10.4166/kjg.2010.56.4.242] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
34 Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol 2020;115:165-78. [PMID: 32023228 DOI: 10.14309/ajg.0000000000000501] [Cited by in Crossref: 60] [Cited by in F6Publishing: 41] [Article Influence: 30.0] [Reference Citation Analysis]
35 Friedman G. Diet and the irritable bowel syndrome. Gastroenterol Clin North Am. 1991;20:313-324. [PMID: 2066155 DOI: 10.1097/01.mog.0000208462.92136.02] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
36 Wallace DJ, Hallegua DS. Fibromyalgia: the gastrointestinal link. Curr Pain Headache Rep 2004;8:364-8. [PMID: 15361320 DOI: 10.1007/s11916-996-0009-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
37 Ghoshal UC, Ghoshal U. Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders. Gastroenterol Clin North Am. 2017;46:103-120. [PMID: 28164845 DOI: 10.1016/j.gtc.2016.09.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
38 Chedid V, Dhalla S, Clarke JO, Roland BC, Dunbar KB, Koh J, Justino E, Tomakin E, Mullin GE. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med 2014;3:16-24. [PMID: 24891990 DOI: 10.7453/gahmj.2014.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
39 Erdrich S, Hawrelak JA, Myers SP, Harnett JE. Determining the association between fibromyalgia, the gut microbiome and its biomarkers: A systematic review. BMC Musculoskelet Disord 2020;21:181. [PMID: 32192466 DOI: 10.1186/s12891-020-03201-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
40 Goebel A, Buhner S, Schedel R, Lochs H, Sprotte G. Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology (Oxford) 2008;47:1223-7. [PMID: 18540025 DOI: 10.1093/rheumatology/ken140] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
41 Ghoshal UC, Srivastava D. Irritable bowel syndrome and small intestinal bacterial overgrowth: Meaningful association or unnecessary hype. World J Gastroenterol 2014; 20(10): 2482-2491 [PMID: 24627585 DOI: 10.3748/wjg.v20.i10.2482] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
42 Marlicz W, Yung DE, Skonieczna-Żydecka K, Loniewski I, van Hemert S, Loniewska B, Koulaouzidis A. From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases. Expert Rev Gastroenterol Hepatol 2017;11:961-78. [PMID: 28618973 DOI: 10.1080/17474124.2017.1343664] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
43 Sekirov I, Russell SL, Antunes LCM, Finlay BB. Gut Microbiota in Health and Disease. Physiological Reviews 2010;90:859-904. [DOI: 10.1152/physrev.00045.2009] [Cited by in Crossref: 2127] [Cited by in F6Publishing: 1884] [Article Influence: 177.3] [Reference Citation Analysis]
44 Roman P, Carrillo-Trabalón F, Sánchez-Labraca N, Cañadas F, Estévez AF, Cardona D. Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review. Benef Microbes 2018;9:603-11. [PMID: 29695180 DOI: 10.3920/BM2017.0125] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
45 Shah A, Holtmann G. Clinical Conditions Associated With Bacterial Overgrowth. Gastrointestinal Diseases and their Associated Infections. Elsevier; 2019. pp. 67-83. [DOI: 10.1016/b978-0-323-54843-4.00006-4] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
46 Vasquez A. Neuroinflammation in fibromyalgia and CRPS is multifactorial. Nat Rev Rheumatol 2016;12:242-242. [DOI: 10.1038/nrrheum.2016.25] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
47 Adkins C, Rezaie A. Small Intestinal Bacterial Overgrowth and Coronary Artery Disease: What Is in the CArDs? Dig Dis Sci 2018;63:271-2. [DOI: 10.1007/s10620-017-4904-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
48 Parodi A, Lauritano E, Nardone G, Fontana L, Savarino V, Gasbarrini A. Small intestinal bacterial overgrowth. Digestive and Liver Disease Supplements 2009;3:44-9. [DOI: 10.1016/s1594-5804(09)60019-x] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
49 Chen B, Kim JJ, Zhang Y, Du L, Dai N. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis. J Gastroenterol 2018;53:807-18. [DOI: 10.1007/s00535-018-1476-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
50 Gupta D, Ghoshal UC, Misra A, Misra A, Choudhuri G, Singh K. Lactose intolerance in patients with irritable bowel syndrome from northern India: a case-control study. J Gastroenterol Hepatol. 2007;22:2261-2265. [PMID: 17559357 DOI: 10.1111/j.1440-1746.2007.04986.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
51 Quigley EM. Probiotics in irritable bowel syndrome: an immunomodulatory strategy? J Am Coll Nutr. 2007;26:684S-690S. [PMID: 18187434 DOI: 10.1080/07315724.2007.10719648] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
52 Katz DL, Greene L, Ali A, Faridi Z. The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation. Medical Hypotheses 2007;69:517-25. [DOI: 10.1016/j.mehy.2005.10.037] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
53 Othman M, Agüero R, Lin HC. Alterations in intestinal microbial flora and human disease. Curr Opin Gastroenterol. 2008;24:11-16. [PMID: 18043226 DOI: 10.1097/mog.0b013e3282f2b0d7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
54 Rezaie A, Pimentel M, Rao SS. How to Test and Treat Small Intestinal Bacterial Overgrowth: An Evidence-Based Approach. Curr Gastroenterol Rep. 2016;18:8. [PMID: 26780631 DOI: 10.1007/s11894-015-0482-9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 11.3] [Reference Citation Analysis]
55 Grover M, Kanazawa M, Palsson OS, Chitkara DK, Gangarosa LM, Drossman DA, Whitehead WE. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress. Neurogastroenterol Motil 2008;20:998-1008. [PMID: 18482250 DOI: 10.1111/j.1365-2982.2008.01142.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 4.6] [Reference Citation Analysis]
56 Silva AR, Bernardo A, Costa J, Cardoso A, Santos P, de Mesquita MF, Vaz Patto J, Moreira P, Silva ML, Padrão P. Dietary interventions in fibromyalgia: a systematic review. Ann Med 2019;51:2-14. [PMID: 30735059 DOI: 10.1080/07853890.2018.1564360] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
57 Kurland JE, Coyle WJ, Winkler A, Zable E. Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci. 2006;51:454-460. [PMID: 16614951 DOI: 10.1007/s10620-006-3154-7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
58 Imajo K, Yoneda M, Ogawa Y, Wada K, Nakajima A. Microbiota and nonalcoholic steatohepatitis. Semin Immunopathol. 2014;36:115-132. [PMID: 24337650 DOI: 10.1007/s00281-013-0404-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
59 Esposito I, Leone A, Gregorio GD, Giaquinto S, Magistris L, Ferrieri A, Riegler G. Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: An observation on non-absorbable antibiotics. World J Gastroenterol 2007; 13(45): 6016-6021 [DOI: 10.3748/wjg.v13.i45.6016] [Reference Citation Analysis]
60 Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol. 2008;103:958-963. [PMID: 18371134 DOI: 10.1111/j.1572-0241.2008.01785.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 99] [Article Influence: 8.6] [Reference Citation Analysis]
61 Grover M, Dorn SD, Weinland SR, Dalton CB, Gaynes BN, Drossman DA. Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders. Dig Dis Sci 2009;54:1284-91. [PMID: 19242800 DOI: 10.1007/s10620-009-0723-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
62 Acay A, Bal A, Oruc S, Ozkececi T, Sariaydin M, Demirbas H, Acarturk G. Does frequency of restless legs syndrome and poor sleep quality increase with age in irritable bowel syndrome? Wien Klin Wochenschr 2016;128:604-9. [DOI: 10.1007/s00508-016-1065-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
63 Ghoshal UC, Srivastava D, Ghoshal U, Misra A. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. European Journal of Gastroenterology & Hepatology 2014;26:753-60. [DOI: 10.1097/meg.0000000000000122] [Cited by in Crossref: 61] [Cited by in F6Publishing: 25] [Article Influence: 7.6] [Reference Citation Analysis]
64 Di Ciaula A, Covelli M, Berardino M, Wang DQ, Lapadula G, Palasciano G, Portincasa P. Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma. BMC Gastroenterol 2008;8:7. [PMID: 18304354 DOI: 10.1186/1471-230X-8-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
65 Shah A, Talley NJ, Jones M, Kendall BJ, Koloski N, Walker MM, Morrison M, Holtmann GJ. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. Am J Gastroenterol 2020;115:190-201. [PMID: 31913194 DOI: 10.14309/ajg.0000000000000504] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 17.5] [Reference Citation Analysis]
66 Chamizo-carmona E. ¿Existe asociación entre la fibromialgia, el aumento de la comorbilidad por enfermedad neoplásica, cardiovascular e infecciones, y el de la mortalidad? Reumatología Clínica 2005;1:200-10. [DOI: 10.1016/s1699-258x(05)72745-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Barbara G, Stanghellini V, Cremon C, De Giorgio R, Gargano L, Cogliandro R, Pallotti F, Corinaldesi R. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. J Clin Gastroenterol 2008;42 Suppl 3 Pt 2:S214-7. [PMID: 18685517 DOI: 10.1097/MCG.0b013e31817da129] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
68 Stanghellini V, Barbara G, Cremon C, Cogliandro R, Antonucci A, Gabusi V, Frisoni C, De Giorgio R, Grasso V, Serra M. Gut microbiota and related diseases: clinical features. Intern Emerg Med. 2010;5 Suppl 1:S57-S63. [PMID: 20865476 DOI: 10.1007/s11739-010-0451-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
69 Wang JC, Sung FC, Men M, Wang KA, Lin CL, Kao CH. Bidirectional association between fibromyalgia and gastroesophageal reflux disease: two population-based retrospective cohort analysis. Pain 2017;158:1971-8. [PMID: 28683023 DOI: 10.1097/j.pain.0000000000000994] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
70 Bested AC, Logan AC, Selhub EM. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual research. Gut Pathog 2013;5:3. [PMID: 23497633 DOI: 10.1186/1757-4749-5-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
71 Gao F, Wang M, Zhang X, Zhang J, Xue Y, Wan H, Wang P. Simultaneous detection of hydrogen and methane in breath for the diagnosis of small intestinal bacterial overgrowth by fast gas chromatography. Anal Methods 2018;10:4329-38. [DOI: 10.1039/c8ay01451e] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
72 Kim YS. Why should gastroenterologists know about fibromyalgia? Common pathogenesis and clinical implications. J Neurogastroenterol Motil 2011;17:1-3. [PMID: 21369484 DOI: 10.5056/jnm.2011.17.1.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
73 Wang KA, Wang JC, Lin CL, Tseng CH. Association between fibromyalgia syndrome and peptic ulcer disease development. PLoS One 2017;12:e0175370. [PMID: 28384332 DOI: 10.1371/journal.pone.0175370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
74 Esposito I, de Leone A, Di Gregorio G, Giaquinto S, de Magistris L, Ferrieri A, Riegler G. Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics. World J Gastroenterol 2007;13:6016-21. [PMID: 18023092 DOI: 10.3748/wjg.v13.45.6016] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
75 Kerckhoffs AP, Visser MR, Samsom M, van der Rest ME, de Vogel J, Harmsen W, Akkermans LM. Critical evaluation of diagnosing bacterial overgrowth in the proximal small intestine. J Clin Gastroenterol. 2008;42:1095-1102. [PMID: 18936644 DOI: 10.1097/mcg.0b013e31818474d7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
76 Basu PP, Shah NJ, Krishnaswamy N, Pacana T. Prevalence of restless legs syndrome in patients with irritable bowel syndrome. World J Gastroenterol 2011; 17(39): 4404-4407 [PMID: 22110266 DOI: 10.3748/wjg.v17.i39.4404] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
77 Silva AR, Bernardo A, de Mesquita MF, Vaz Patto J, Moreira P, Silva ML, Padrão P. A study protocol for a randomized controlled trial of an anti-inflammatory nutritional intervention in patients with fibromyalgia. Trials 2021;22:198. [PMID: 33743794 DOI: 10.1186/s13063-021-05146-3] [Reference Citation Analysis]
78 Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol. 2005;100:1566-1570. [PMID: 15984983 DOI: 10.1111/j.1572-0241.2005.40795.x] [Cited by in Crossref: 123] [Cited by in F6Publishing: 115] [Article Influence: 7.2] [Reference Citation Analysis]
79 Logan AC, Katzman M. Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses. 2005;64:533-538. [PMID: 15617861 DOI: 10.1016/j.mehy.2004.08.019] [Cited by in Crossref: 145] [Cited by in F6Publishing: 125] [Article Influence: 8.5] [Reference Citation Analysis]
80 Ponziani FR, Gerardi V, Gasbarrini A. Diagnosis and treatment of small intestinal bacterial overgrowth. Expert Rev Gastroenterol Hepatol. 2016;10:215-227. [PMID: 26636484 DOI: 10.1586/17474124.2016.1110017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
81 Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin. World J Gastroenterol 2009; 15(21): 2628-2631 [PMID: 19496193 DOI: 10.3748/wjg.15.2628] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
82 Mathieu N. Comorbidités somatiques dans le Syndrome de l’Intestin Irritable : fibromyalgie, syndrome de fatigue chronique et cystite interstitielle/syndrome de la vessie douloureuse. Gastroentérologie Clinique et Biologique 2009;33:S17-25. [DOI: 10.1016/s0399-8320(09)71521-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
83 Kessoku T, Kobayashi T, Tanaka K, Yamamoto A, Takahashi K, Iwaki M, Ozaki A, Kasai Y, Nogami A, Honda Y, Ogawa Y, Kato S, Imajo K, Higurashi T, Hosono K, Yoneda M, Usuda H, Wada K, Saito S, Nakajima A. The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target. Int J Mol Sci 2021;22:8161. [PMID: 34360923 DOI: 10.3390/ijms22158161] [Reference Citation Analysis]
84 Rana SV, Sharma S, Malik A, Kaur J, Prasad KK, Sinha SK, Singh K. Small intestinal bacterial overgrowth and orocecal transit time in patients of inflammatory bowel disease. Dig Dis Sci. 2013;58:2594-2598. [PMID: 23649377 DOI: 10.1007/s10620-013-2694-x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 6.9] [Reference Citation Analysis]
85 Parodi A, Sessarego M, Greco A, Bazzica M, Filaci G, Setti M, Savarino E, Indiveri F, Savarino V, Ghio M. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol. 2008;103:1257-1262. [PMID: 18422815 DOI: 10.1111/j.1572-0241.2007.01758.x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 70] [Article Influence: 6.4] [Reference Citation Analysis]